List of Oklahoma Medical Research Foundation patents

Patents where

Current Assignee

Name

Oklahoma Medical Research Foundation

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7410642 Assays and therapies for latent viral infection	Patent 7410642 was granted and assigned to Oklahoma Medical Research Foundation on August, 2008 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7410642	August 12, 2008
‌ US Patent 7078173 Assays and therapies for latent viral infection	Patent 7078173 was granted and assigned to Oklahoma Medical Research Foundation on July, 2006 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7078173	July 18, 2006
‌ US Patent 7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement	Patent 7166568 was granted and assigned to Oklahoma Medical Research Foundation on January, 2007 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7166568	January 23, 2007
‌ US Patent 7119166 Universal procedure for refolding recombinant proteins	Patent 7119166 was granted and assigned to Oklahoma Medical Research Foundation on October, 2006 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7119166	October 10, 2006
‌ US Patent 7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders	Patent 7192715 was granted and assigned to Oklahoma Medical Research Foundation on March, 2007 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7192715	March 20, 2007
‌ US Patent 7592003 Regulation of toll-like receptors on stem cells	Patent 7592003 was granted and assigned to Oklahoma Medical Research Foundation on September, 2009 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7592003	September 22, 2009
‌ US Patent 8420595 Methods for treating acute acoustic trauma	Patent 8420595 was granted and assigned to Oklahoma Medical Research Foundation on April, 2013 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	8420595	April 16, 2013
‌ US Patent 7332334 Hematopoietic stem cells treated by in vitro fucosylation and methods of use	Patent 7332334 was granted and assigned to Oklahoma Medical Research Foundation on February, 2008 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7332334	February 19, 2008
‌ US Patent 11458187 Extracellular histones as biomarkers for prognosis and molecular targets for therapy		Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	11458187	October 4, 2022
‌ US Patent 10393739 Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare	Patent 10393739 was granted and assigned to Oklahoma Medical Research Foundation on August, 2019 by the United States Patent and Trademark Office.	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	10393739	August 27, 2019
‌ US Patent 7444014 Extended depth of focus microscopy	Patent 7444014 was granted and assigned to Oklahoma Medical Research Foundation on October, 2008 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7444014	October 28, 2008
‌ US Patent 7291333 Blockade of protein C activation reduces microvascular surgical blood loss	Patent 7291333 was granted and assigned to Oklahoma Medical Research Foundation on November, 2007 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7291333	November 6, 2007
‌ US Patent 11585810 Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare		Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	11585810	February 21, 2023
‌ US Patent 7259251 3′ UTR of the human prohibitin gene	Patent 7259251 was granted and assigned to Oklahoma Medical Research Foundation on August, 2007 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7259251	August 21, 2007
‌ US Patent 11567077 Human		Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	11567077	January 31, 2023
‌ US Patent 8716218 Extracellular histones as biomarkers for prognosis and molecular targets for therapy	Patent 8716218 was granted and assigned to Oklahoma Medical Research Foundation on May, 2014 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	8716218	May 6, 2014
‌ US Patent 10350261 Extracellular histones as biomarkers for prognosis and molecular targets for therapy	Patent 10350261 was granted and assigned to Oklahoma Medical Research Foundation on July, 2019 by the United States Patent and Trademark Office.	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	10350261	July 16, 2019
‌ US Patent 9474748 Adjuvant chemotherapy for anaplastic gliomas	Patent 9474748 was granted and assigned to Oklahoma Medical Research Foundation on October, 2016 by the United States Patent and Trademark Office.	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	9474748	October 25, 2016
‌ US Patent 10238711 Extracellular histones as biomarkers for prognosis and molecular targets for therapy	Patent 10238711 was granted and assigned to Oklahoma Medical Research Foundation on March, 2019 by the United States Patent and Trademark Office.	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	10238711	March 26, 2019
‌ US Patent 10398659 Adjuvant chemotherapy for anaplastic gliomas	Patent 10398659 was granted and assigned to Oklahoma Medical Research Foundation on September, 2019 by the United States Patent and Trademark Office.	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	10398659	September 3, 2019
‌ US Patent 9968569 Adjuvant chemotherapy for anaplastic gliomas	Patent 9968569 was granted and assigned to Oklahoma Medical Research Foundation on May, 2018 by the United States Patent and Trademark Office.	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	9968569	May 15, 2018
‌ US Patent 7794732 Anthrax compositions and methods of use and production	Patent 7794732 was granted and assigned to Oklahoma Medical Research Foundation on September, 2010 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	7794732	September 14, 2010
‌ US Patent 9511095 Cells treated by in vitro fucosylation and methods of production and use thereof	Patent 9511095 was granted and assigned to Oklahoma Medical Research Foundation on December, 2016 by the United States Patent and Trademark Office.	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	9511095	December 6, 2016
‌ US Patent 8633249 Adjuvant chemotherapy for anaplastic gliomas	Patent 8633249 was granted and assigned to Oklahoma Medical Research Foundation on January, 2014 by the United States Patent and Trademark Office.		Oklahoma Medical Research Foundation	United States Patent and Trademark Office	8633249	January 21, 2014
‌ US Patent 9279815 Human	Patent 9279815 was granted and assigned to Oklahoma Medical Research Foundation on March, 2016 by the United States Patent and Trademark Office.	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	United States Patent and Trademark Office	9279815	March 8, 2016

Results per page:

58 results

0 selected

58 results

0 selected